Financial Oversight and Management Bd. for P. R. v. Centro De Periodismo Investigativo, Inc. ( 2023 )


Menu:
  • (Slip Opinion)              OCTOBER TERM, 2022                                       1
    Syllabus
    NOTE: Where it is feasible, a syllabus (headnote) will be released, as is
    being done in connection with this case, at the time the opinion is issued.
    The syllabus constitutes no part of the opinion of the Court but has been
    prepared by the Reporter of Decisions for the convenience of the reader.
    See United States v. Detroit Timber & Lumber Co., 
    200 U. S. 321
    , 337.
    SUPREME COURT OF THE UNITED STATES
    Syllabus
    FINANCIAL OVERSIGHT AND MANAGEMENT BOARD
    FOR PUERTO RICO v. CENTRO DE PERIODISMO
    INVESTIGATIVO, INC.
    CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR
    THE FIRST CIRCUIT
    No. 22–96. Argued January 11, 2023—Decided May 11, 2023
    In 2016, Congress passed the Puerto Rico Oversight, Management, and
    Economic Stability Act (PROMESA), 
    48 U. S. C. §2101
     et seq., to deal
    with a fiscal crisis in Puerto Rico brought about by soaring public debt.
    PROMESA establishes a system for overseeing Puerto Rico’s finances,
    while also enabling the Commonwealth to gain bankruptcy protections
    similar to those available under the Federal Bankruptcy Code. See
    Financial Oversight and Management Bd. for Puerto Rico v. Aurelius
    Investment, LLC, 
    590 U. S. ___
    , ___. The statute creates the Financial
    Oversight and Management Board for Puerto Rico—petitioner in this
    case—as an “entity within the territorial government” of Puerto Rico.
    §2121(c)(1). Under PROMESA, the Board approves the Common-
    wealth’s fiscal plans and budgets, supervises its borrowing, and repre-
    sents Puerto Rico in so-called Title III cases—judicial debt-restructur-
    ing proceedings modeled on federal bankruptcy proceedings.
    Beginning in 2016, respondent Centro de Periodismo Investigativo,
    Inc. (CPI)—a nonprofit media organization that has reported on
    Puerto Rico’s fiscal crisis—asked the Board to release various docu-
    ments relating to its work. When CPI’s requests went unfulfilled, it
    sued the Board in the United States District Court for Puerto Rico,
    citing a provision of the Puerto Rican Constitution interpreted to guar-
    antee a right of access to public records. The Board moved to dismiss
    on sovereign immunity grounds, but the District Court rejected that
    defense. The First Circuit affirmed. The court began by citing Circuit
    precedent that Puerto Rico enjoys sovereign immunity, and it assumed
    without deciding that the Board shares in that immunity. But it then
    held that PROMESA—particularly its jurisdictional provision, Section
    2 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Syllabus
    2126(a)—clearly abrogates the Board’s immunity.
    Held: Nothing in PROMESA—including its jurisdictional provision, Sec-
    tion 2126(a)—categorically abrogates any sovereign immunity the
    Board enjoys from legal claims. This Court assumes without deciding
    that Puerto Rico is immune from suit in United States district court,
    and that the Board partakes of that immunity. See Cutter v. Wil-
    kinson, 
    544 U. S. 709
    , 718, n. 7.
    This Court has often held that Congress must make its intent to ab-
    rogate sovereign immunity “unmistakably clear in the language of the
    statute.” Kimel v. Florida Bd. of Regents, 
    528 U. S. 62
    , 73. The Court
    has applied that clear-statement rule in cases naming the federal gov-
    ernment, States, and Indian tribes as defendants. And it has found
    that standard met in only two situations: when a statute says, in so
    many words, that it is stripping immunity from a sovereign entity, e.g.,
    
    35 U. S. C. §296
    (a), and when a statute creates a cause of action and
    authorizes suit against a government on that claim, see, e.g., Kimel,
    
    528 U. S., at
    73–74. PROMESA fits neither of these molds. Except by
    reference to the Bankruptcy Code in Title III debt-restructuring pro-
    ceedings, see 
    11 U. S. C. §106
    (a); 
    48 U. S. C. §2161
    (a), PROMESA does
    not provide that the Board or Puerto Rico is subject to suit. Nor does
    PROMESA create any cause of action for use against the Board or
    Puerto Rico. Thus, Congress has not, through a means this Court has
    recognized, “ma[de] its intention” to abrogate immunity “unmistaka-
    bly clear.” Kimel, 
    528 U. S., at 73
    .
    CPI claims to identify the required clear statement in PROMESA’s
    establishment of a judicial review scheme. Section 2126(a) provides
    that “any action against the Oversight Board, and any action other-
    wise arising out of” PROMESA, “shall be brought” in the Federal Dis-
    trict Court for Puerto Rico. In CPI’s view, that provision—especially
    when combined with Section 2126(c)’s allusion to “declaratory or in-
    junctive relief against the Oversight Board”—contemplates that the
    Board would be subject to suit in federal court. But those provisions
    serve a function even absent a categorical abrogation of immunity, in
    cases where the Board’s immunity has been waived or abrogated by
    other statutes. For example, Title VII of the Civil Rights Act abrogates
    the immunity of “governments” and “governmental agencies” from all
    actions it authorizes. 42 U. S. C. §§2000e(a)–(b). If a Board employee
    were fired because of race, Section 2126(a) would tell the employee
    where to bring the suit and Section 2126(c) would govern the timing of
    injunctive and declaratory relief. Nor do protections that PROMESA
    provides the Board from litigation fill the gap. Again, CPI is wrong to
    think those provisions “superfluous” unless PROMESA generally ab-
    rogates the Board’s immunity. Section 2125’s protection of Board
    members from monetary liability would do work whenever some other
    Cite as: 
    598 U. S. ____
     (2023)                     3
    Syllabus
    law abrogated or waived the Board’s immunity from specific claims.
    In such a case, the claim could go forward, but Section 2125 would stop
    the award of money damages. And Section 2126(e)’s bar on challenges
    to the Board’s fiscal and budgetary decisions would do work whenever
    a plaintiff sought to get around the Board’s sovereign immunity via an
    Ex parte Young action against an individual Board member. See Vir-
    ginia Office for Protection and Advocacy v. Stewart, 
    563 U. S. 247
    , 254–
    255.
    In short, nothing in PROMESA makes Congress’s intent to abrogate
    the Board’s sovereign immunity unmistakably clear. The statute does
    not explicitly strip the Board of immunity or expressly authorize the
    bringing of claims against the Board. And its judicial review provi-
    sions and liability protections are compatible with the Board’s gener-
    ally retaining sovereign immunity. Pp. 5–11.
    
    35 F. 4th 1
    , reversed and remanded.
    KAGAN, J., delivered the opinion of the Court, in which ROBERTS, C. J.,
    and ALITO, SOTOMAYOR, GORSUCH, KAVANAUGH, BARRETT, and JACKSON,
    JJ., joined. THOMAS, J., filed a dissenting opinion.
    Cite as: 
    598 U. S. ____
     (2023)                              1
    Opinion of the Court
    NOTICE: This opinion is subject to formal revision before publication in the
    United States Reports. Readers are requested to notify the Reporter of
    Decisions, Supreme Court of the United States, Washington, D. C. 20543,
    pio.supremecourt.gov, of any typographical or other formal errors.
    SUPREME COURT OF THE UNITED STATES
    _________________
    No. 22–96
    _________________
    FINANCIAL OVERSIGHT AND MANAGEMENT BOARD
    FOR PUERTO RICO, PETITIONER v. CENTRO DE
    PERIODISMO INVESTIGATIVO, INC.
    ON WRIT OF CERTIORARI TO THE UNITED STATES COURT OF
    APPEALS FOR THE FIRST CIRCUIT
    [May 11, 2023]
    JUSTICE KAGAN delivered the opinion of the Court.
    A recently enacted federal statute establishes a financial
    oversight board within the Commonwealth of Puerto Rico’s
    government. The question presented is whether the statute
    categorically abrogates (legalspeak for eliminates) any sov-
    ereign immunity the board enjoys from legal claims. We
    hold it does not. Under long-settled law, Congress must use
    unmistakable language to abrogate sovereign immunity.
    Nothing in the statute creating the board meets that high
    bar.
    I
    Congress passed the Puerto Rico Oversight, Manage-
    ment, and Economic Stability Act of 2016 (PROMESA), 
    48 U. S. C. §2101
     et seq., to deal with a fiscal emergency.
    Puerto Rico’s public debt had soared, to more than the an-
    nual output of the island’s economy. The Commonwealth
    could not service that level of debt through the bond mar-
    kets. And it was not eligible to restructure debt under the
    Federal Bankruptcy Code. PROMESA offered a path out of
    2 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Opinion of the Court
    the crisis, helping Puerto Rico “to achieve fiscal responsibil-
    ity and access to the capital markets.” §2121(a). The idea
    was to set up a system for overseeing Puerto Rico’s finances,
    while also enabling the Commonwealth to gain bankruptcy
    protections similar to those available under the Code. See
    Financial Oversight and Management Bd. for Puerto Rico
    v. Aurelius Investment, LLC, 
    590 U. S. ___
    , ___–___ (2020)
    (slip op., at 3–4).
    PROMESA creates, as its centerpiece, the Financial
    Oversight and Management Board for Puerto Rico—the pe-
    titioner here. The statute describes the seven-member
    Board as an “entity within the territorial government” of
    Puerto Rico. §2121(c)(1). And this Court has affirmed that
    the Board’s structure, duties, and powers make it “part of
    the local Puerto Rican government.” Id., at ___ (slip op., at
    14). Under PROMESA, the Board approves and enforces
    the Commonwealth’s fiscal plans and budgets, and super-
    vises the Commonwealth’s borrowing. See §§2141–2144,
    2147. The Board also represents Puerto Rico in so-called
    Title III cases—judicial proceedings, modeled on federal
    bankruptcy proceedings, for restructuring the Common-
    wealth’s (and its instrumentalities’) debt. See §§2161–
    2177.
    With one exception, PROMESA says nothing explicit
    about abrogating sovereign immunity. The exception is for
    Title III cases, and comes via the Federal Bankruptcy Code.
    PROMESA incorporates, as part of its mechanism for re-
    structuring debt, the Code’s express abrogation of sovereign
    immunity. See §2161(a) (incorporating 
    11 U. S. C. §106
     for
    “case[s] under [Title III]”). But as to all other matters
    PROMESA addresses, Congress did not mention sovereign
    immunity. In particular, no provision states that it is abro-
    gating any immunity the Board possesses from legal claims.
    At the same time, several provisions of PROMESA con-
    template that, even outside the Title III context, the Board
    may confront legal claims against it. Most fundamentally,
    Cite as: 
    598 U. S. ____
     (2023)                      3
    Opinion of the Court
    Section 2126(a), entitled “Jurisdiction,” states that “any ac-
    tion against the Oversight Board, and any action otherwise
    arising out of ” PROMESA, “shall be brought” in the Federal
    District Court sitting in Puerto Rico.1 And Section 2126(c)
    anticipates that those actions may lead to orders “granting
    declaratory or injunctive relief against the Oversight
    Board”; under the provision, such orders cannot take effect
    until the litigation is over.
    On the flipside, PROMESA sets certain limits on litiga-
    tion targeting the Board. Section 2125 forecloses monetary
    liability against the Board, its members, and its employees
    for “actions taken to carry out” the statute. And Section
    2126(e) provides that no district court will have jurisdiction
    over challenges to the Board’s “certification determina-
    tions”—mainly, decisions approving Puerto Rico’s fiscal
    plans and budgets. See §§2141(e), 2142(e) (describing those
    determinations).
    The suit before us demands that the Board release vari-
    ous documents relating to its work. Respondent Centro de
    Periodismo Investigativo, Inc. (CPI) is a nonprofit media or-
    ganization that has published many reports on Puerto
    Rico’s fiscal crisis and the debt-restructuring process. In
    2016, CPI asked the Board to turn over a broad array of
    materials, including communications between the Board’s
    members and Puerto Rican and U. S. officials. When the
    request went unanswered, CPI sued the Board in the Fed-
    eral District Court in Puerto Rico. CPI cited a provision of
    the Puerto Rican Constitution interpreted to guarantee a
    right of access to public records. And it requested an in-
    junction ordering the records’ release.
    The Board moved to dismiss the suit on the ground that,
    ——————
    1 The section contains two exceptions not relevant here—one for appli-
    cations to enforce subpoenas, the other for certain actions related to Title
    III cases. See 
    48 U. S. C. §§2124
    (f )(2), 2166(a)(2).
    4 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Opinion of the Court
    as an arm of the Puerto Rican government, it enjoys sover-
    eign immunity. The District Court denied the motion, rea-
    soning that Congress had abrogated the Board’s immunity
    in PROMESA—particularly, in Section 2126(a)’s jurisdic-
    tional provision. See App. to Pet. for Cert. 74a–76a. While
    the parties fought over unresolved privilege issues, CPI
    brought a second suit seeking another set of documents.
    The Board again invoked sovereign immunity, and the
    court again denied the defense. See 
    id.,
     at 56a–57a. Orders
    in both suits were consolidated for appeal.
    The Court of Appeals for the First Circuit affirmed the
    denial of immunity, over a dissent. See 
    35 F. 4th 1
     (2022).
    The court began by citing Circuit precedent that Puerto
    Rico (like a State or Indian tribe) enjoys sovereign immun-
    ity. It then “assume[d] without deciding” that the Board
    shares in Puerto Rico’s immunity, noting that CPI had not
    contested that issue. 
    Id., at 15
    . That was the Board’s final
    piece of good news—for the court next held that PROMESA
    abrogates the Board’s (assumed) immunity. Congress may
    abrogate sovereign immunity, the court noted, “by making
    its intention unmistakably clear in the language of the stat-
    ute.” 
    Ibid.
     (quoting Kimel v. Florida Bd. of Regents, 
    528 U. S. 62
    , 73 (2000)). And Congress had done so, the court
    held, in Section 2126(a): The “grant of jurisdiction” there
    “unequivocally stated [Congress’s] intention that the Board
    could be sued” in federal district court. 35 F. 4th, at 17. The
    court found additional support for its holding in Sections
    2126(c) and (e). The former, the court reasoned, “contem-
    plates” orders of “declaratory and injunctive relief ” against
    the Board. Ibid. And the latter, in making certification
    challenges unreviewable, “implies” that all other claims
    against the Board fall within Section 2126(a)’s scope. Ibid.
    Judge Lynch disagreed. She would have held that Congress
    had not adequately “set[ ] forth an intent to abrogate” the
    Board’s immunity, whether in Section 2126(a)’s jurisdic-
    tional grant or in any other provision. Id., at 21.
    Cite as: 
    598 U. S. ____
     (2023)                     5
    Opinion of the Court
    We granted certiorari, 
    598 U. S. ___
     (2022), and now re-
    verse.
    II
    The question on which we granted certiorari is whether
    PROMESA—and particularly its jurisdictional provision—
    abrogates the Board’s immunity. See Brief for Oversight
    Board i. As thus framed, the question asks only about ab-
    rogation, while taking the Board’s underlying immunity as
    a given. That framing accords with how this case played
    out in the courts below. Because Circuit precedent had set-
    tled Puerto Rico’s own immunity, the lower courts barely
    addressed the question. See, e.g., 35 F. 4th, at 13–14. Sim-
    ilarly for the Board’s immunity. CPI never argued that the
    Commonwealth’s immunity did not extend to the Board;
    and for that reason, the courts below simply assumed the
    Board’s immunity before turning to the abrogation issue.
    See, e.g., id., at 14–15. We took the case on those terms,
    and we resolve it on those terms. See, e.g., Cutter v. Wil-
    kinson, 
    544 U. S. 709
    , 718, n. 7 (2005) (“[W]e are a court of
    review, not of first view”). That means we assume without
    deciding that Puerto Rico is immune from suit in federal
    district court, and that the Board partakes of that immun-
    ity. We address only whether, accepting those premises,
    PROMESA effects an abrogation.2
    ——————
    2 CPI now asks us to extend our review to the underlying immunity
    issue. CPI still does not contest that the Board shares in whatever im-
    munity Puerto Rico possesses. But it argues here that Puerto Rico’s im-
    munity applies only in its own courts—not in federal courts. See Brief
    for CPI 29–32. The Government also urges us to address Puerto Rico’s
    immunity, though to come out the other way: It reads our precedents as
    supporting immunity in both territorial and federal courts. See Brief for
    United States as Amicus Curiae 16–19 (citing, e.g., Porto Rico v. Rosaly
    y Castillo, 
    227 U. S. 270
    , 273–277 (1913)). We decline the two invitations
    for the reasons just stated: The proceedings below did not examine those
    matters, and we agreed to tackle only the abrogation question. Cf. Puerto
    Rico Aqueduct and Sewer Authority v. Metcalf & Eddy, Inc., 
    506 U. S. 139
    , 141, n. 1 (1993) (similarly declining to address whether Puerto Rico
    6 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Opinion of the Court
    The standard for finding a congressional abrogation is
    stringent. Congress, this Court has often held, must make
    its intent to abrogate sovereign immunity “unmistakably
    clear in the language of the statute.” E.g., Kimel, 
    528 U. S., at 73
     (internal quotation marks omitted); see also Sossa-
    mon v. Texas, 
    563 U. S. 277
    , 287 (2011) (“[W]here a statute
    is susceptible of multiple plausible interpretations,” we will
    not read it to strip immunity). We have invoked that clear-
    statement rule, and applied it equivalently, in cases nam-
    ing the federal government, States, and Indian tribes as de-
    fendants. See, e.g., FAA v. Cooper, 
    566 U. S. 284
    , 290–291
    (2012); Kimel, 
    528 U. S., at 73
    ; Michigan v. Bay Mills In-
    dian Community, 
    572 U. S. 782
    , 790 (2014).3 CPI argues
    that the rule should not likewise apply to Puerto Rico, citing
    Congress’s plenary power over Territories. See Brief for
    CPI 25–26 (“The concept of plenary power” is “incompatible
    with forcing Congress to express its intent unequivocally”).
    But we have similarly described Congress’s power over the
    tribes, and still demand that Congress “unequivocally ex-
    press” an intent to abrogate their immunity. Bay Mills, 
    572 U. S., at 790
     (internal quotation marks omitted); see 
    ibid.
    (“Although Congress has plenary authority over tribes,
    courts will not lightly assume that Congress in fact intends”
    to abrogate their immunity). Our precedent thus conveys a
    consistent message: If a defendant enjoys sovereign im-
    munity (which we are assuming the Board does), abroga-
    tion requires an “unequivocal declaration” from Congress.
    Dellmuth v. Muth, 
    491 U. S. 223
    , 232 (1989).
    ——————
    has sovereign immunity when holding that an order denying immunity
    for one of its instrumentalities is immediately appealable). We also note
    that this suit—in which Puerto Rico itself plays no role—would be a sin-
    gularly inapt vehicle to resolve Puerto Rico’s immunity.
    3 Of course, when the federal government is the defendant, the clear-
    statement rule operates to identify a waiver of its own immunity, rather
    than an abrogation of another government’s.
    Cite as: 
    598 U. S. ____
     (2023)            7
    Opinion of the Court
    The Court has found that standard met in only two situ-
    ations. The first is when a statute says in so many words
    that it is stripping immunity from a sovereign entity. Con-
    gress, for example, has provided that States “shall not be
    immune,” under any “doctrine of sovereign immunity, from
    suit in Federal court” for patent or copyright infringement.
    
    35 U. S. C. §296
    (a); 
    17 U. S. C. §511
    (a). Those provisions,
    we have noted, “could not have made any clearer Congress’s
    intent” to abrogate immunity. Allen v. Cooper, 
    589 U. S. ___
    , ___ (2020) (slip op., at 5) (internal quotation marks and
    alterations omitted). The second is when a statute creates
    a cause of action and authorizes suit against a government
    on that claim. Take the Age Discrimination in Employment
    Act (ADEA) or the Family and Medical Leave Act (FMLA).
    We held that each abrogated sovereign immunity by au-
    thorizing suits against employers—specifically including
    governments—for violating the statute’s provisions (i.e., for
    discriminating or denying leave). See Kimel, 
    528 U. S., at
    73–74; Nevada Dept. of Human Resources v. Hibbs, 
    538 U. S. 721
    , 726 (2003). Or consider the Indian Gaming Reg-
    ulatory Act (IGRA). We likewise saw an abrogation in its
    authorization of tribal suits against States for violating
    their statutory duty to negotiate about gaming compacts.
    See Seminole Tribe of Fla. v. Florida, 
    517 U. S. 44
    , 56–57
    (1996). True enough, none of those Acts expressly declared
    sovereigns non-immune (as the patent and copyright laws
    did). But all expressly authorized suits against sovereigns
    in service of enforcing statutory requirements. And recog-
    nizing immunity would have negated those authorizations:
    The very suits allowed against governments would auto-
    matically have been dismissed.
    PROMESA fits neither of those two molds. Except in Ti-
    tle III debt-restructuring proceedings (not at issue here),
    the statute does not provide that the Board or Puerto Rico
    is subject to suit. See supra, at 2. And indeed, the exception
    8 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Opinion of the Court
    implies the opposite as a general rule. The immunity pro-
    vision that PROMESA borrows from the Bankruptcy Code
    for Title III cases states: “[S]overeign immunity is abro-
    gated as to a governmental unit,” including a “Territory.”
    
    11 U. S. C. §106
    (a), incorporated by 
    48 U. S. C. §2161
    (a); 
    11 U. S. C. §101
    (27). Congress chose not to adopt similar lan-
    guage to govern other kinds of litigation involving the
    Board. See, e.g., Badgerow v. Walters, 
    596 U. S. ___
    , ___
    (2022) (slip op., at 8) (“When Congress includes particular
    language in one section of a statute but omits it in another
    section of the same Act, we generally take the choice to be
    deliberate”). Too, PROMESA does not create any cause of
    action (or otherwise approve any claim) for use against the
    Board or Puerto Rico. So recognizing immunity under
    PROMESA would not—as in the ADEA, FMLA, and IGRA
    cases—authorize a suit against a sovereign with one hand,
    only to bar it with the other. Instead, immunity would op-
    erate in the ordinary way—to protect a sovereign from a
    host of claims Congress has not otherwise said may proceed.
    The upshot is evident: Congress has not, through a means
    we have recognized, “ma[de] its intention” to abrogate im-
    munity “unmistakably clear.” Kimel, 
    528 U. S., at 73
     (in-
    ternal quotation marks omitted).
    CPI contends we can still find a clear statement in
    PROMESA, based on the statute’s establishment of a judi-
    cial review scheme. The primary provision in CPI’s argu-
    ment (as in the First Circuit’s, see supra, at 4) is Section
    2126(a): “[A]ny action against the Oversight Board, and any
    action otherwise arising out of ” PROMESA, “shall be
    brought” in the Federal District Court for Puerto Rico. In
    CPI’s view, that provision—especially when combined with
    Section 2126(c)’s allusion to “declaratory or injunctive relief
    against the Oversight Board”—expresses Congress’s “clear
    intent to subject the Board to suit in federal court.” Brief
    for CPI 16. CPI backs up that argument by pointing to pro-
    Cite as: 
    598 U. S. ____
     (2023)             9
    Opinion of the Court
    visions insulating the Board (and its members and employ-
    ees) from monetary liability and barring suits challenging
    the Board’s budgetary decisions. See 
    id.,
     at 15–16, 38–40;
    see supra, at 3. Those protections, CPI maintains, would
    have no point “if the Board were immune generally.” Brief
    for CPI 16. So taken together (says CPI), PROMESA’s ju-
    dicial review provisions are “incompatible with sovereign
    immunity.” Id., at 35.
    But all those provisions serve a function without our
    reading an abrogation of immunity into PROMESA. In Sec-
    tions 2126(a) and (c), Congress indeed contemplated the
    possibility of suits—and of relief—against the Board. And
    wisely so—because litigation against the Board can arise
    even though the Board enjoys sovereign immunity gener-
    ally. For one thing, statutes other than PROMESA abro-
    gate the Board’s immunity from particular claims. See gen-
    erally supra, at 7. Consider Title VII of the Civil Rights Act,
    prohibiting various kinds of employment discrimination.
    That law, this Court has held, validly abrogates the immun-
    ity of “governments” and “governmental agencies” from all
    actions it authorizes. 42 U. S. C. §§2000e(a)–(b); see Fitz-
    patrick v. Bitzer, 
    427 U. S. 445
    , 447–448 (1976). So if a
    Board employee were fired because of race, Section 2126(a)
    would tell him where to bring his suit and Section 2126(c)
    would govern the timing of injunctive and declaratory re-
    lief. And for another thing, the Board could decide to waive
    its immunity from particular suits or claims. Were it to do
    so, Sections 2126(a) and (c) would again kick in. So
    PROMESA’s judicial review scheme—absent a categorical
    abrogation of immunity—still has plenty of work to do. For
    similar reasons, this Court has held that other jurisdic-
    tional and judicial review provisions were insufficient to es-
    tablish an abrogation. See Blatchford v. Native Village of
    Noatak, 
    501 U. S. 775
    , 786, and n. 4 (1991); Dellmuth, 
    491 U. S., at 231
    . Here, as there, providing for a judicial forum
    does not make the requisite clear statement.
    10 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    Opinion of the Court
    Nor do the litigation protections in PROMESA fill the
    gap. At the most basic level, it would be peculiar to read
    shields from lawsuits as unmistakably subjecting the Board
    to lawsuits (by abrogating immunity). But aside from that,
    CPI is wrong to think that those shields would be “point-
    less” or “superfluous” unless PROMESA generally abro-
    gates the Board’s immunity. Brief for CPI 38. Consider
    first Section 2125’s protection of the Board, its employees,
    and its members from monetary liability for carrying out
    PROMESA. That provision would do work whenever, as
    discussed above, some other law abrogated or waived the
    Board’s immunity from specific claims. In such a case, the
    claim could go forward, but Section 2125 would stop the
    award of money damages. Of particular note, that section
    would limit the Board’s liability in Title III cases, in which
    PROMESA has indeed abrogated immunity. See supra, at
    2. And last, Section 2125 protects individuals—the Board’s
    members and employees—not covered by the Board’s sover-
    eign immunity. All in all, that seems like more than enough
    to explain the provision’s existence. Similarly for Section
    2126(e), which prevents challenges to the Board’s fiscal and
    budgetary decisions. Yes, sovereign immunity insulates
    the Board itself from those attacks. But without Section
    2126(e), a plaintiff might get around that immunity via an
    Ex parte Young action—a suit against an individual Board
    member for injunctive relief. See Virginia Office for Protec-
    tion and Advocacy v. Stewart, 
    563 U. S. 247
    , 254–255 (2011)
    (describing the Ex parte Young “limit on the sovereign-
    immunity principle”). Section 2126(e) precludes that possi-
    bility. So it too has a role to play in a scheme with sovereign
    immunity.
    In short, nothing in PROMESA makes Congress’s intent
    to abrogate the Board’s sovereign immunity “unmistakably
    clear.” Kimel, 
    528 U. S., at 73
    . The statute does not explic-
    itly strip the Board of immunity. It does not expressly au-
    thorize the bringing of claims against the Board. And its
    Cite as: 
    598 U. S. ____
     (2023)            11
    Opinion of the Court
    judicial review provisions and liability protections are com-
    patible with the Board’s generally retaining sovereign im-
    munity. We therefore reverse the judgment of the Court of
    Appeals and remand the case for further proceedings con-
    sistent with this opinion.
    It is so ordered.
    Cite as: 
    598 U. S. ____
     (2023)           1
    THOMAS, J., dissenting
    SUPREME COURT OF THE UNITED STATES
    _________________
    No. 22–96
    _________________
    FINANCIAL OVERSIGHT AND MANAGEMENT BOARD
    FOR PUERTO RICO, PETITIONER v. CENTRO DE
    PERIODISMO INVESTIGATIVO, INC.
    ON WRIT OF CERTIORARI TO THE UNITED STATES COURT OF
    APPEALS FOR THE FIRST CIRCUIT
    [May 11, 2023]
    JUSTICE THOMAS, dissenting.
    At every stage of these proceedings, respondent has ar-
    gued that petitioner lacks state sovereign immunity. Peti-
    tioner has consistently replied that it has that immunity
    and that nothing abrogates it. The courts below, bound by
    Circuit precedent, held that petitioner does have state sov-
    ereign immunity—but they also held that the immunity has
    been abrogated. The Court today disagrees with only that
    latter conclusion, holding that nothing abrogates peti-
    tioner’s immunity, but it “assume[s] without deciding” the
    logically antecedent question whether petitioner enjoys
    that immunity in the first place. Ante, at 5. In doing so,
    the majority effectively decides the outcome of this case.
    Because I would reach the antecedent question and hold
    that petitioner lacks the only immunity it has ever as-
    serted, I respectfully dissent.
    Respondent, Centro de Periodismo Investigativo, Inc.
    (CPI), sued petitioner, the Financial Oversight and Man-
    agement Board for Puerto Rico, over a document-disclosure
    dispute. The Board moved to dismiss the lawsuit by invok-
    ing state sovereign immunity, which the Board claimed to
    possess as an arm of the Puerto Rican territorial govern-
    ment. CPI responded (both in the District Court and on ap-
    peal) that Puerto Rico has no such immunity and that, even
    2 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    THOMAS, J., dissenting
    if it did, that immunity would be abrogated by the Puerto
    Rico Oversight, Management, and Economic Stability Act
    (PROMESA), 
    48 U. S. C. §2101
     et seq. Bound by Circuit
    precedent holding that Puerto Rico enjoys state sovereign
    immunity, each court below rejected CPI’s first argument.
    See 
    35 F. 4th 1
    , 14 (CA1 2022). But the courts below also
    agreed with CPI’s second argument that the Board’s im-
    munity was abrogated.
    When the Board asked us to review that holding, CPI
    once again raised its lead argument, pointing out that we
    logically could not reverse the First Circuit’s judgment
    without first addressing whether the Board actually has the
    immunity that the Board claims has not been abrogated.
    And, in its merits brief, CPI made Puerto Rico’s lack of state
    sovereign immunity its lead argument. There is nothing
    more that CPI could have done to preserve this antecedent,
    dispositive argument.
    Yet the majority skips it entirely, “assum[ing] without de-
    ciding that Puerto Rico is immune from suit in federal dis-
    trict court”—while also deciding that PROMESA does not
    abrogate that assumed immunity. Ante, at 5. In doing so,
    it effectively consigns CPI’s case to the dustbin, remanding
    back to a Circuit where Circuit precedent will dictate the
    outcome. CPI might be forgiven for wondering whether we
    granted certiorari only insofar as our review would favor
    the Board.
    The majority asserts that it need not address CPI’s argu-
    ment because “[t]he proceedings below did not examine
    these matters, and we agreed to tackle only the abrogation
    question.” 
    Ibid.
     But it is unclear why the court below would
    have examined the matter any further, given its precedent.1
    ——————
    1 The fact that the First Circuit barely addressed the issue below,
    simply noting Circuit precedent, is surely irrelevant; we have often
    granted certiorari on questions that were resolved below with drive-by
    citations to binding precedent, sometimes in footnotes. See, e.g., App. to
    Pet. for Cert. in Lora v. United States, O. T. 2022, No. 22–49, p. 11a, n. 3;
    Cite as: 
    598 U. S. ____
     (2023)                      3
    THOMAS, J., dissenting
    And, “[t]his issue is predicate to an intelligent resolution of
    the question presented,” as it makes no sense to analyze
    whether PROMESA abrogates state sovereign immunity
    without first determining whether that immunity is impli-
    cated at all. United States v. Grubbs, 
    547 U. S. 90
    , 94, n. 1
    (2006) (internal quotation marks omitted).2 Because I
    think the Court has a duty to pass upon issues that are
    fairly presented, preserved by the parties, and necessary to
    support its judgment, I would consider whether the Board
    has the immunity it asserts.
    From the start, the Board has asserted only that it pos-
    sesses what it has called “Eleventh Amendment immunity.”
    The First Circuit agreed, explaining that it “has long
    treated Puerto Rico like a state for Eleventh Amendment
    purposes.” 35 F. 4th, at 14. However, the plain text of the
    Eleventh Amendment applies only to lawsuits brought
    against a State by citizens of another State. And, because
    CPI is a resident of Puerto Rico, I can only assume that the
    Board and the First Circuit meant to refer to the sovereign
    immunity that is inherent in the 50 States. See Allen v.
    Cooper, 
    589 U. S. ___
    , ___ (2020) (slip op., at 4).
    As we have explained, inherent state sovereign immunity
    reflects the original design of the Constitution. See Fran-
    chise Tax Bd. of Cal. v. Hyatt, 
    587 U. S. ___
    , ___–___ (2019)
    (slip op., at 5–12). At the Founding, the “States considered
    ——————
    App. to Pet. for Cert. in Smith v. United States, O. T. 2022, No. 21–1576,
    p. 15a.
    2 We have often recognized the need to address such logically anteced-
    ent questions. See, e.g., Caterpillar Inc. v. Lewis, 
    519 U. S. 61
    , 75, n. 13
    (1996); see also Vance v. Terrazas, 
    444 U. S. 252
    , 258–259, n. 5 (1980)
    (collecting cases). For example, we explained in Grubbs that it would
    “mak[e] little sense to address what the Fourth Amendment requires of
    anticipatory search warrants if it does not allow them at all.” 
    547 U. S., at 94, n. 1
    . And, in Rumsfeld v. Forum for Academic and Institutional
    Rights, Inc., 
    547 U. S. 47
     (2006), we explained that “granting certiorari
    to determine whether a statute is constitutional fairly includes the ques-
    tion of what that statute says.” 
    Id., at 56
    .
    4 FINANCIAL OVERSIGHT AND MANAGEMENT BD. FOR P. R.
    v. CENTRO DE PERIODISMO INVESTIGATIVO, INC.
    THOMAS, J., dissenting
    themselves fully sovereign nations,” and part of that sover-
    eignty “was their immunity from private suits.” 
    Id.,
     at ___
    (slip op., at 6) (internal quotation marks omitted). When
    advocating for the Constitution’s ratification, leading Fed-
    eralists then assured their opponents that the Constitution
    would not allow private citizens to hale States into federal
    court without their consent. See 
    ibid.
     Though this Court
    held otherwise soon thereafter in Chisholm v. Georgia, 
    2 Dall. 419
     (1793), the Eleventh Amendment’s swift ratifica-
    tion confirmed that Chisholm was wrong. See Hyatt, 587
    U. S., at ___–___ (slip op., at 11–12). Thus, in general, the
    Constitution does not allow federal or state courts to hear
    cases against States without their consent. See id., at ___–
    ___ (slip op., at 13–16); Alden v. Maine, 
    527 U. S. 706
    , 730–
    731 (1999). This deeply rooted rule “inheres in the system
    of federalism” that the Constitution establishes. See 
    id., at 730
    .3
    Here, however, all sides agree that Puerto Rico is a Ter-
    ritory, not a State. See Puerto Rico v. Sánchez Valle, 
    579 U. S. 59
    , 75–77 (2016). Accordingly, it is difficult to see how
    the same inherent sovereign immunity that the States en-
    joy in federal court would apply to Puerto Rico. To be sure,
    the United States has urged us to hold that Puerto Rico en-
    joys a form of common-law immunity that, it claims, terri-
    torial governments can invoke in federal court. See Brief
    for United States as Amicus Curiae 16–19. But the Board
    has, at every stage, argued only that it possesses the same
    immunity as States. That argument appears untenable.
    ——————
    3 The Court has described this unique form of sovereign immunity as
    belonging to the 13 original States by dint of their post-Independence
    and pre-Ratification independent sovereignty and to the subsequently
    admitted States as a result of their admission to the Union on an equal
    footing with the original States. Alden, 
    527 U. S., at 713
    ; see also Mich-
    igan v. Bay Mills Indian Community, 
    572 U. S. 782
    , 816, n. 1 (2014)
    (THOMAS, J., dissenting); accord, Hyatt, 587 U. S., at ___–___ (slip op., at
    11–14) (noting unique nature of state sovereign immunity).
    Cite as: 
    598 U. S. ____
     (2023)          5
    THOMAS, J., dissenting
    And, as the party asserting an immunity, the Board should
    have the burden of establishing its immunity. Because the
    Board has failed to do so, I would rule in CPI’s favor and
    affirm the judgment below.
    I respectfully dissent.